OHDSI Home | Forums | Wiki | Github

[Pharmacovigilance Evidence Investigation Workgroup] Meetings

Researchers
#1

Hi,

This coming week we will be starting up monthly meetings for Pharmacovigilence Evidence Investigation Workgroup (was LAERTES or Knowledge Base). The new meeting time is Wednesday 9am Eastern using GoToMeeting (see below).

Topics we plan to discuss include:

  • advancing a new user interface design for the PV evidence base (https://goo.gl/ErBifr)

  • updating and expanding the PV evidence base

  • applying causal learning and discovery to PV evidence

Others are welcome to suggest additional topics of interest.

Kind regards,
-Rich

MEETING INFO:
Please join my meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/530277469

You can also dial in using your phone.
United States: +1 (224) 501-3217

Access Code: 530-277-469

More phone numbers
Canada: +1 (647) 497-9350
France: +33 170 950 594
Netherlands: +31 207 941 377
Sweden: +46 853 527 836
Switzerland: +41 225 4599 78
United Kingdom: +44 330 221 0088

#3

Hi Rich,

I’d like to learn more about LAERTES and the ongoing projects. We have some people at Eli Lilly who are interested in using LAERTES to capture negative controls. It would be also great to discuss the process and have a quick demo how it works.

Looking forward to the meeting!

Thanks,
Hamed

#5

Hi, this is a reminder that tomorrow 8/22 we will have our monthly meeting of the Pharmacovigilance Evidence Investigation Workgroup at 9am Eastern using GoToMeeting (see below).

Topics we plan to discuss include:

  • advancing a new user interface design for the PV evidence base (https://goo.gl/ErBifr) – we have new use case to go over: https://goo.gl/SxAjne

  • updating and expanding the PV evidence base

  • applying causal learning and discovery to PV evidence

Others are welcome to suggest additional topics of interest.

Kind regards,
-Rich

MEETING INFO:
Please join my meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/530277469

You can also dial in using your phone.
United States: +1 (224) 501-3217

Access Code: 530-277-469

More phone numbers
Canada: +1 (647) 497-9350
France: +33 170 950 594
Netherlands: +31 207 941 377
Sweden: +46 853 527 836
Switzerland: +41 225 4599 78
United Kingdom: +44 330 221 0088

#6

This design really looks great, Rich et al. Sorry I was unable to join the call.

I have gotten SPLICER running again and seems to be functioning well. If there is a particular set of high priority labels, please send my way and I can run them first.

Thanks!

Jon

#7

Hi Jon, I am planning to update the knowledge base and include recent launched products. Please let me know if I can be of any help.

Hamed

#8

Hi, this is a reminder that this Wednesday 9/13 we will have our monthly meeting of the Pharmacovigilance Evidence Investigation Workgroup at 9am Eastern using GoToMeeting (see below).

Topics we plan to discuss include:

  • advancing a new user interface design for the PV evidence base (https://goo.gl/ErBifr) – we plan to go over one more new use case

  • updating and expanding the PV evidence base

  • applying causal learning and discovery to PV evidence

Others are welcome to suggest additional topics of interest.

Kind regards,-Rich

MEETING INFO:Please join my meeting from your computer, tablet or smartphone.https://global.gotomeeting.com/join/530277469

You can also dial in using your phone.United States: +1 (224) 501-3217

Access Code: 530-277-469

More phone numbers Canada: +1 (647) 497-9350 France: +33 170 950 594 Netherlands: +31 207 941 377 Sweden: +46 853 527 836 Switzerland: +41 225 4599 78 United Kingdom: +44 330 221 0088

#9

Reminder of our workgroup meeting coming up Wed 9/27 at 9am Eastern. I suggest that we focus on any new use cases and then on discussing the following paper which describes the approach that I plan to use to update PubMed MeSH data sources in LAERTES later this fall:

Winnenburg R, Sorbello A, Ripple A, Harpaz R, Tonning J, Szarfman A, Francis H, Bodenreider O. Leveraging MEDLINE indexing for pharmacovigilance – inherent limitations and mitigation strategies. Journal of Biomedical Informatics 2015;57:425–435. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775467/

As always, other are welcome to suggest additional topics of interest.

Kind regards,-Rich

MEETING INFO:Please join my meeting from your computer, tablet or smartphone.https://global.gotomeeting.com/join/530277469

You can also dial in using your phone.United States: +1 (224) 501-3217

Access Code: 530-277-469

More phone numbers Canada: +1 (647) 497-9350 France: +33 170 950 594 Netherlands: +31 207 941 377 Sweden: +46 853 527 836 Switzerland: +41 225 4599 78 United Kingdom: +44 330 221 0088

#10

Hi, this is a reminder that tomorrow 11/8 we will have meeting of the Pharmacovigilance Evidence Investigation Workgroup at 9:30am Eastern using GoToMeeting (see below).

Topics we plan to discuss include:

Others are welcome to suggest additional topics of interest.

Kind regards,-R

Please join my meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/530277469

You can also dial in using your phone.
United States: +1 (224) 501-3217

Access Code: 530-277-469

More phone numbers
Canada: +1 (647) 497-9350
France: +33 170 950 594
Netherlands: +31 207 941 377
Sweden: +46 853 527 836
Switzerland: +41 225 4599 78
United Kingdom: +44 330 221 0088

First GoToMeeting? Try a test session: https://care.citrixonline.com/g2m/getready

t